Orthopaedic Manifestations of Mucopolysaccharidosis. [PDF]
Tremonti C, Bui E, White KK, Steinman S.
europepmc +1 more source
Mucopolysaccharidosis Type II Screening, Diagnosis, and Management: A Literature Review and Practical Recommendations for Newborn Screening Programs and Health Care Providers to Support Families and Improve Outcomes. [PDF]
Gaviglio A +7 more
europepmc +1 more source
Mucopolysaccharidosis (MPS) type VI: A case series to assess the efficacy of enzyme replacement therapy and to guide precision-based medicine in the IRISH paediatric cohort. [PDF]
Mathew C +7 more
europepmc +1 more source
Synthesis of the endogenous non-reducing end heparan sulfate disaccharides for newborn screening and diagnosis of mucopolysaccharidosis types I and II. [PDF]
Singh G +4 more
europepmc +1 more source
Advances in Therapeutic Options for Pulmonary and Sleep Disorders in Mucopolysaccharidosis (MPS) Patients: A Narrative Review. [PDF]
Akpa B.
europepmc +1 more source
[Case of mucopolysaccharidosis II--Hunter's syndrome].
M, Walczak +3 more
openaire +1 more source
Related searches:
Nasal Polyposis in mucopolysaccharidosis type II
BMJ Case Reports, 2021Mucopolysaccharidosis (MPS) type II is a rare multisystem disorder resulting from the accumulation of breakdown products of glycosaminoglycans in the body tissues. Many patients with this disease undergo ENT (ear, nose and throat) surgeries such as adenotonsillectomy and tympanocentesis at a very early age, much before the diagnosis of MPS.
Sushmitha Kabekkodu +3 more
openaire +2 more sources

